Literature DB >> 11559719

Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer.

A Goldhirsch1, J H Glick, R D Gelber, A S Coates, H J Senn.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11559719     DOI: 10.1200/JCO.2001.19.18.3817

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  103 in total

1.  A web-based system for individualised survival estimation in breast cancer.

Authors:  Johan Lundin; Mikael Lundin; Jorma Isola; Heikki Joensuu
Journal:  BMJ       Date:  2003-01-04

2.  Population-based study of the relationship of treatment and sociodemographics on quality of life for early stage breast cancer.

Authors:  Nancy K Janz; Mahasin Mujahid; Paula M Lantz; Angela Fagerlin; Barbara Salem; Monica Morrow; Dennis Deapen; Steven J Katz
Journal:  Qual Life Res       Date:  2005-08       Impact factor: 4.147

3.  Locoregional recurrence risk factors in breast cancer patients with positive axillary lymph nodes and the impact of postmastectomy radiotherapy.

Authors:  Tomoya Nagao; Takayuki Kinoshita; Nobuko Tamura; Takashi Hojo; Madoka Morota; Yoshikazu Kagami
Journal:  Int J Clin Oncol       Date:  2011-11-09       Impact factor: 3.402

4.  The roles of teaching hospitals, insurance status, and race/ethnicity in receipt of adjuvant therapy for regional-stage breast cancer in Florida.

Authors:  Lisa C Richardson; Lili Tian; Lydia Voti; Abraham G Hartzema; Isildinha Reis; Lora E Fleming; Jill Mackinnon
Journal:  Am J Public Health       Date:  2005-11-29       Impact factor: 9.308

5.  Lymph node ratio is more valuable than level III involvement for prediction of outcome in node-positive breast carcinoma patients.

Authors:  Emin Yildirim; Ugur Berberoglu
Journal:  World J Surg       Date:  2007-02       Impact factor: 3.352

6.  The role of biological markers as predictors of response to preoperative chemotherapy in large primary breast cancer.

Authors:  Veronique F Cocquyt; Vera R Schelfhout; Phillip N Blondeel; Herman T Depypere; Kristof K Daems; Rudolphe F Serreyn; Marleen M Praet; Simon J P Van Belle
Journal:  Med Oncol       Date:  2003       Impact factor: 3.064

7.  Adjuvant ovarian suppression in premenopausal breast cancer.

Authors:  Prudence A Francis; Meredith M Regan; Gini F Fleming; István Láng; Eva Ciruelos; Meritxell Bellet; Hervé R Bonnefoi; Miguel A Climent; Gian Antonio Da Prada; Harold J Burstein; Silvana Martino; Nancy E Davidson; Charles E Geyer; Barbara A Walley; Robert Coleman; Pierre Kerbrat; Stefan Buchholz; James N Ingle; Eric P Winer; Manuela Rabaglio-Poretti; Rudolf Maibach; Barbara Ruepp; Anita Giobbie-Hurder; Karen N Price; Marco Colleoni; Giuseppe Viale; Alan S Coates; Aron Goldhirsch; Richard D Gelber
Journal:  N Engl J Med       Date:  2014-12-11       Impact factor: 91.245

8.  Chemotherapy use for hormone receptor-positive, lymph node-negative breast cancer.

Authors:  Michael J Hassett; Melissa E Hughes; Joyce C Niland; Stephen B Edge; Richard L Theriault; Yu-Ning Wong; John Wilson; W Bradford Carter; Douglas W Blayney; Jane C Weeks
Journal:  J Clin Oncol       Date:  2008-10-27       Impact factor: 44.544

Review 9.  Lymphatic metastasis in breast cancer: importance and new insights into cellular and molecular mechanisms.

Authors:  Suzanne Eccles; Lenaic Paon; Jonathan Sleeman
Journal:  Clin Exp Metastasis       Date:  2007-11-06       Impact factor: 5.150

Review 10.  Optical tomography of breast cancer-monitoring response to primary medical therapy.

Authors:  Louise C Enfield; Adam P Gibson; Jeremy C Hebden; Michael Douek
Journal:  Target Oncol       Date:  2009-09-24       Impact factor: 4.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.